Literature DB >> 16307344

Hydrothorax due to ventriculopleural shunting in a child with spina bifida on chronic dialysis: third ventriculostomy as an alternative of cerebrospinal diversion.

Jose Grunberg1, Anabella Rébori, María Cristina Verocay, Virginia Ramela, Ricardo Alberti, Alvaro Cordoba.   

Abstract

The purpose of this paper is to describe the risks of ventriculopleural shunt in patients with spina bifida and end-stage-renal-diseases (ESRD), and to describe endoscopic third ventriculostomy as an alternative for the combination of cerebrospinal shunt and dialysis modality. We report a 16-year-old boy with spina bifida on chronic dialysis with a massive unilateral hydrothorax and respiratory distress complicating a ventriculopleural (VPL) shunt. Two thoracocenteses were performed, draining 3200 ml of a clear fluid. The VPL shunt was removed and revised successfully to a third ventriculostomy (TVE). Peritoneal dialysis (PD) was the initial dialysis modality. After 12 months on PD, the patient was transferred to hemodialysis (HD) because of refractory peritonitis. Hydrothorax developed while the patient was on PD, reaching its maximum 2 months after the transference to HD. To our knowledge there has been no other report of ventriculopleural (VPL) shunt failure, and endoscopic TVE, as a cerebrospinal fluid (CSF) diversion alternative in patients on chronic dialysis.

Entities:  

Mesh:

Year:  2005        PMID: 16307344     DOI: 10.1007/s11255-005-0398-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

1.  Delayed complication of a ventriculopleural shunt.

Authors:  N Donnelly; J Jayamohan; A J Moore
Journal:  Br J Neurosurg       Date:  2001-04       Impact factor: 1.596

2.  Neuroendoscopic third ventriculostomy for failed shunts.

Authors:  Neil Buxton; Donald Macarthur; Iain Robertson; Jonathan Punt
Journal:  Surg Neurol       Date:  2003-09

3.  Advisability of initiating chronic peritoneal dialysis in the presence of a ventriculoperitoneal shunt.

Authors:  B A Warady; S Hellerstein; U Alon
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

4.  Tension hydrothorax due to ventriculopleural shunting.

Authors:  C Beach; D E Manthey
Journal:  J Emerg Med       Date:  1998 Jan-Feb       Impact factor: 1.484

5.  Symptomatic pleural collection of cerebrospinal fluid caused by a ventriculopleural shunt.

Authors:  D Y Sanders; R Summers; L DeRouen
Journal:  South Med J       Date:  1997-03       Impact factor: 0.954

6.  Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus.

Authors:  S Tuli; J Drake; J Lawless; M Wigg; M Lamberti-Pasculli
Journal:  J Neurosurg       Date:  2000-01       Impact factor: 5.115

7.  CSF induced sclerosing peritonitis: a new entity?

Authors:  G LaFerla; K E McColl; G P Crean
Journal:  Br J Surg       Date:  1986-01       Impact factor: 6.939

8.  [Ventriculopleural shunt to treat hydrocephalus].

Authors:  J Torres Lanzas; A Ríos Zambudio; J F Martínez Lage; M J Roca Calvo; M Poza; P Parrilla Paricio
Journal:  Arch Bronconeumol       Date:  2002-11       Impact factor: 4.872

Review 9.  Peritoneal dialysis in children with spina bifida and ventriculoperitoneal shunt: one center's experience and review of the literature.

Authors:  José Grunberg; Anabella Rebori; María Cristina Verocay
Journal:  Perit Dial Int       Date:  2003 Sep-Oct       Impact factor: 1.756

  9 in total
  3 in total

1.  CSF Hydrothorax as a Late Complication of Ventriculoatrial Shunt Catheter Displacement.

Authors:  Ertuğrul Çakır; Erhan Arslan
Journal:  Balkan Med J       Date:  2014-12-01       Impact factor: 2.021

2.  Pleural effusion following ventriculopleural shunt: Case reports and review of the literature.

Authors:  Elif Küpeli; Cem Yilmaz; Sule Akçay
Journal:  Ann Thorac Med       Date:  2010-07       Impact factor: 2.219

3.  Severe respiratory failure following ventriculopleural shunt.

Authors:  Shahzad Alam; Nagaraju M Manjunath
Journal:  Indian J Crit Care Med       Date:  2015-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.